Bridgeway Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$127K Buy
2025
Q1
$82.1K Buy
2024
Q4
$124K Buy
2020
Q2
Sell
2020
Q1
$283K Sell
2019
Q4
$629K Buy
2019
Q3
$596K Buy
2019
Q2
$789K Hold
2019
Q1
$1.03M Buy
2018
Q4
$515K Hold
2018
Q3
$1.23M Buy